Immunity against HIV/ADIS, malaria, and tuberculosis during co-infections with neglected infectious diseases: Recommendations for the European Union research priorities

PLoS Neglected Tropical Diseases

Volumn 2, Issue 6, 2008, Pages

  Boraschi, Diana ^a   Alemayehu, Markos Abebe ^b   Aseffa, Abraham ^b   Chiodi, Francesca ^c   Chisi, John ^d   Del Prete, Gianfranco ^e   Doherty, T Mark ^f   Elhassan, Ibrahim ^g   Engers, Howard ^b   Gyan, Ben ^h   Harandi, Ali M ⁱ   Kariuki, Thomas ^j   Kironde, Fred ^k   Kouriba, Bourema ^l   Langhorne, Jean ^m   Laskay, Tamás ⁿ   Medaglini, Donata ^o   Olesen, Ole ^p   Onyebujoh, Philip ^q   Palma, Carla ^r   Sauerwein, Robert ^s   Sibanda, Elopy ^t   Steinhoff, Ulrich ^u   Tagliabue, Aldo ^v   Thiel, Andreas ^w   Vahedi, Mahnaz ^q   Troye Blomberg, Marita ^x   more..

^a CNR   (Italy)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF MALAWI   (Malawi)

^e UNIVERSITY OF FLORENCE   (Italy)

^f STATENS SERUM INSTITUT   (Denmark)

^g UNIVERSITY OF KHARTOUM   (Sudan)

^h University of Ghana   (Ghana)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^k MAKERERE UNIVERSITY   (Uganda)

^l UNIVERSITY OF BAMAKO   (Mali)

^m NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

ⁿ UNIVERSITY OF LÜBECK   (Germany)

^o UNIVERSITY OF SIENA   (Italy)

^p EUROPEAN COMMISSION   (Belgium)

^q WORLD HEALTH ORGANIZATION   (Switzerland)

^r ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^s RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^t UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^u MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^v ALTA   (Italy)

^w DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^x STOCKHOLM UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AFRICAN TRYPANOSOMIASIS; ARTICLE; CHOLERA; DEVELOPING COUNTRY; DISABILITY; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; EDUCATION; ETHIOPIA; EUROPEAN UNION; HELMINTHIASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOGENETICS; IMMUNOLOGICAL MEMORY; MALARIA; MALNUTRITION; MEDICAL RESEARCH; MIXED INFECTION; MORTALITY; OUTCOMES RESEARCH; PARASITOSIS; RURAL AREA; SOCIOECONOMICS; TUBERCULOSIS; URBAN AREA; ANIMAL; COMMUNICABLE DISEASE; IMMUNOLOGY; RESEARCH; STANDARD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; COMMUNICABLE DISEASES; EUROPEAN UNION; HIV INFECTIONS; HUMANS; MALARIA; RESEARCH; TUBERCULOSIS;

EID: 48949118088     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000255     Document Type: Article

References (20)

1. Editorial (2007) Remembering the neglected tropical diseases. Lancet 370: 1880.
2. Molyneux DH, Hotez PJ, Fenwick A (2005) "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2: e336. doi:10.1371/journal.pmed.0020336.
3. Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the Global Burden of Disease framework. PLoS Negl Tropical Dis 1: e114. doi: 10.1371/journal.pntd.0000114.
4. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Sachs SE, Sachs JD (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs fro HIV/AIDS, tuberculosis, and malaria. PLoS Med 3: e 102. doi:10.1371/journal.pmed.0030102.
5. Hotez PJ, Molyneux DH, Stillwaggon E, Bentwich Z, Kumaresan J (2006) Neglected tropical diseases and HIV/AIDS. Lancet 368: 1865-1866.
6. Council Decision 971/2006/CE of 19/12/2006 adopting a Specific Programme for Research, Technological Development and Demonstration: 'Cooperation' (2007-2013). Official Journal of the European Union, L 54 of 22 February 2007, p. 30.
7. TDR business plan 2008-2013. Geneva, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2007 (TDR/GEN/ EN/07.1/Rev.1).
8. Keen J, Serghides L, Ayi K, Patel SN, Ayisi J, et al. (2007) HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med 4: el8l. doi:10.1371/journal.pmed.0040181.
9. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
10. van Riet E, Hartgers FC, Yazdanbakhsh M (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212: 475-490.
11. Elias D, Britton S, Kassu A, Akuffo H (2007) Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther 5: 475-484.
12. Dybul M (2006) Neglected tropical diseases and HIV/AIDS. Lancet 368: 1865.
13. Epstein MA (1984) Burkitt's lymphoma: clues to the role of malaria. Nature 312: 398.
14. Ramaswamy M, Geretti AM (2007) Interactions and management issues in HSV and HIV coinfection. Expert Rev Anti Infect Ther 5: 231-243.
15. Prentice AM, Ghattas H, Doherty C, Cox SE (2007) Iron metabolism and malaria. Food Nutr Bull 28: S524-S539.
16. Reiche EM, Bonametti AM, Vottarelli JC, Morimoto HK, Watanabe MA (2007) Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type I infection (HIV-1). Curr Med Chem 14: 1325-1334.
17. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, et al. (2006) Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 38: 230-245.
18. Ferwerda B, McCall ME, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, et al. (2007) TLR4 polymorphims, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 104: 16645-16650.
19. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, et al. (2007) A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523-528.
20. Ebensen T, Guzmán CA (2008) Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. Hum Vaccin 4: 13-22.